CBSA creates
co-opportunity
for the Colorado
life sciences
community.

Learn about our momentum in the Life Sciences Impact Report.

Read about our global impact in the new BioScience Colorado Magazine.

Learn More
Life Sciences Impact Capital + Growth Policy + Advocacy

Colorado BioScience Institute

Our workforce cultivation activities build knowledge, skills and leadership capabilities.

Learn More

Why Colorado

Our robust economy, collaborative culture, leading academic and research institutions, pro-innovation business climate, and excellent quality of life make Colorado a leading choice to start, scale or relocate a life sciences business.

Learn More

Networking + Events

CBSACommunity
More
15
Thursday, Jul 15, 2021
9:00—10:00am

Next Event

Regulatory Symposium Virtual Series

15
Thursday, Jul 15, 2021
9:00—10:00am
CBSA and Hogan Lovells bring you four virtual sessions on Thursday, July 15, July 22, July 29, August 5, 2021 from 9:00—10:00am MT.
Learn More
21
Monday, Jun 21, 2021
8:00am—5:00pm

Next Event

Arab Health 2021

21
Monday, Jun 21, 2021
8:00am—5:00pm
Learn More

Stay up to date with one of the country’s most dynamic life sciences ecosystems. Subscribe to the CBSA newsletter today.

Subscribe

News + Blog

CBSA NewsEcosystem News
More

A Letter from CBSA President & CEO Jennifer Jones Paton: 2021 Legislative Session

Learn More

Legislative Session Closes – CBSA Reviews Policy Accomplishments

Learn More

Join Our Team at Colorado BioScience Association

Learn More

Policy Wins for Colorado Life Sciences Community with SB 175 Amendments

Learn More

Weekly Policy Update: Two State Bills Move Forward That Could Adversely Impact Life Sciences Ecosystem

Learn More

The Top 25 Women Leaders in Consumer HealthTech of 2021, CBSA Congratulates Tasha Bond from member company Sana Health

Learn More

Lohocla Research to Present at 2021 BIO

Learn More

EvoEndo Raises $10.1 Million to Make Unsedated Transnasal Endoscopy a Reality for Patients and Physicians

Learn More

FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

Learn More

Foresight Diagnostics Completes Series A Financing to Accelerate Development of its Industry-Leading Minimal Residual Disease (MRD) Technology

Learn More